Ortin Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 11.57 million compared to INR 16.59 million a year ago. Revenue was INR 11.68 million compared to INR 16.59 million a year ago. Net income was INR 4.56 million compared to net loss of INR 0.901 million a year ago. Basic earnings per share from continuing operations was INR 0.56 compared to basic loss per share from continuing operations of INR 0.11 a year ago. Diluted earnings per share from continuing operations was INR 0.56 compared to diluted loss per share from continuing operations of INR 0.11 a year ago.
For the nine months, sales was INR 45.64 million compared to INR 59.37 million a year ago. Revenue was INR 45.77 million compared to INR 59.74 million a year ago. Net income was INR 1.1 million compared to INR 0.546 million a year ago. Basic earnings per share from continuing operations was INR 0.14 compared to INR 0.07 a year ago. Diluted earnings per share from continuing operations was INR 0.14 compared to INR 0.07 a year ago.